NO20041300L - Flavanolignanpreparater med okt loselighet - Google Patents

Flavanolignanpreparater med okt loselighet

Info

Publication number
NO20041300L
NO20041300L NO20041300A NO20041300A NO20041300L NO 20041300 L NO20041300 L NO 20041300L NO 20041300 A NO20041300 A NO 20041300A NO 20041300 A NO20041300 A NO 20041300A NO 20041300 L NO20041300 L NO 20041300L
Authority
NO
Norway
Prior art keywords
flavanolignan
solubility
oct
compositions
approaches
Prior art date
Application number
NO20041300A
Other languages
English (en)
Norwegian (no)
Inventor
Kvetoslava Benesova
Ladislav Cvak
Milan Stuchlik
Original Assignee
Ivax Pharmaceuticals Sro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivax Pharmaceuticals Sro filed Critical Ivax Pharmaceuticals Sro
Publication of NO20041300L publication Critical patent/NO20041300L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20041300A 2001-08-30 2004-03-29 Flavanolignanpreparater med okt loselighet NO20041300L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20013153A CZ292832B6 (cs) 2001-08-30 2001-08-30 Způsob přípravy silymarinu se zvýšenou rozpustností
PCT/US2002/027713 WO2003020291A1 (en) 2001-08-30 2002-08-30 Increased solubility flavanolignan preparations

Publications (1)

Publication Number Publication Date
NO20041300L true NO20041300L (no) 2004-03-29

Family

ID=5473538

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041300A NO20041300L (no) 2001-08-30 2004-03-29 Flavanolignanpreparater med okt loselighet

Country Status (15)

Country Link
US (1) US7384919B2 (cs)
EP (1) EP1420802B1 (cs)
JP (1) JP2005519863A (cs)
KR (1) KR20040074052A (cs)
CN (1) CN1582159A (cs)
AT (1) ATE381340T1 (cs)
AU (1) AU2002323517B2 (cs)
CA (1) CA2458963A1 (cs)
CZ (1) CZ292832B6 (cs)
DE (1) DE60224202T2 (cs)
MX (1) MXPA04001700A (cs)
NO (1) NO20041300L (cs)
NZ (1) NZ531429A (cs)
TW (1) TWI238065B (cs)
WO (1) WO2003020291A1 (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005026755A1 (de) * 2005-06-09 2006-12-14 Basf Ag Herstellung von festen Lösungen schwerlöslicher Wirkstoffe durch Kurzzeitüberhitzung und schnelle Trocknung
JP5596547B2 (ja) * 2007-10-17 2014-09-24 エフ． オボカイティス，トッド 化合物の固体状態を変化させる方法、及びその方法で製造した共アモルファス組成物
DE102008039271A1 (de) * 2007-12-23 2009-06-25 Euromed Sa Neuer Mariendistelextrakt, Verfahren zur Herstellung und Verwendung
CZ2008407A3 (cs) 2008-06-26 2009-08-26 Agra Group, A. S. Vodorozpustný prípravek na bázi flavanonol lignanu a zpusob jeho prípravy
TWI529167B (zh) * 2009-05-14 2016-04-11 歐羅梅德股份有限公司 用於治療病毒性肝炎之非晶型水飛薊賓
WO2010134519A1 (ja) * 2009-05-19 2010-11-25 サントリーホールディングス株式会社 フロフラン型リグナン4位グルコース転移酵素、及びそれをコードするポリヌクレオチド
CN102228430B (zh) * 2011-06-14 2015-12-09 中国中医科学院中药研究所 水飞蓟宾磷脂复合物的纳米混悬剂及其制备方法
US8877259B2 (en) 2012-02-09 2014-11-04 Mary Kay Inc. Cosmetic formulation
ITMI20121317A1 (it) * 2012-07-27 2014-01-28 Indena Spa Composizioni per il trattamento della fatica oncologica
JP2015113332A (ja) * 2013-12-16 2015-06-22 花王株式会社 生薬粉体
US10202598B2 (en) 2014-05-30 2019-02-12 Todd Frank Ovokaitys Methods and systems for generation, use, and delivery of activated stem cells
US10040728B2 (en) 2014-06-06 2018-08-07 Todd Frank Ovokaitys Methods and compositions for increasing the bioactivity of nutrients
US10384985B2 (en) 2014-06-06 2019-08-20 B.K. Consultants, Inc. Methods and compositions for increasing the yield of, and beneficial chemical composition of, certain plants
JP6348024B2 (ja) * 2014-09-03 2018-06-27 株式会社ファンケル 水分散性の良いシリマリン含有組成物
KR101598752B1 (ko) 2015-01-28 2016-02-29 순천향대학교 산학협력단 표면적 및/또는 다공성이 조절된 당알콜을 담체로 이용한 리포솜 조성물 및 그의 제조방법
ES2706008B8 (es) * 2017-09-22 2021-07-12 Euromed S A Procedimiento para la preparacion de una composicion a partir del cardo mariano y composicion obtenida
KR20230129426A (ko) 2020-12-08 2023-09-08 토드 프랭크 오보케이티스 줄기 세포 생산 증가를 위한 방법 및 시스템

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1554662A (en) * 1976-05-05 1979-10-24 Inverni Della Beffa Spa Polyhydroxyphenylchromanones
IT1215291B (it) * 1985-07-17 1990-01-31 Inverni Della Beffa Spa Complessi di flavanolignani con fosfolipidi, loro preparazione e relative composizioni farmaceutiche.
US4767508A (en) * 1986-02-27 1988-08-30 Nippon Mining Co., Ltd. Strike plating solution useful in applying primer plating to electronic parts
IT1222012B (it) * 1987-07-10 1990-08-31 Indena Spa Composizioni farmaceutiche e cosmetiche contenenti complessi di flavonolignani con fosfolipidi
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US5019562A (en) * 1988-01-19 1991-05-28 The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation Growth inhibiting agent and the use thereof
IT1241673B (it) * 1989-10-09 1994-01-27 Istituto Biochimico Italiano Complessi di inclusione di silibinina con ciclodestrina, loro preparazione e composizioni farmaceutiche che li contengono.
US5196448A (en) * 1991-01-22 1993-03-23 Stiefel Laboratories, Inc. Antiinflammatory compositions and method of use
DE19501266A1 (de) * 1995-01-18 1996-07-25 Madaus Ag Verfahren zur Herstellung von Flavano-Lignan-Zubereitungen mit verbesserter Freisetzung und Resorbierbarkeit danach erhältliche Zubereitungen und deren Verwendung zur Herstellung von Arzneimitteln
CZ287657B6 (cs) 1996-06-12 2001-01-17 Mikrobiologický Ústav Av Čr Glykosidy silybininu a způsob jejich výroby
DE19744459A1 (de) 1997-10-08 1999-04-15 Schwabe Willmar Gmbh & Co Flavonolignan-Zubereitungen, insbesondere Silymarin-Zubereitungen

Also Published As

Publication number Publication date
DE60224202T2 (de) 2008-12-04
JP2005519863A (ja) 2005-07-07
US7384919B2 (en) 2008-06-10
CZ292832B6 (cs) 2003-12-17
DE60224202D1 (de) 2008-01-31
US20050101546A1 (en) 2005-05-12
AU2002323517B2 (en) 2009-12-10
CZ20013153A3 (cs) 2003-04-16
CN1582159A (zh) 2005-02-16
EP1420802B1 (en) 2007-12-19
ATE381340T1 (de) 2008-01-15
EP1420802A4 (en) 2005-02-09
MXPA04001700A (es) 2005-04-11
KR20040074052A (ko) 2004-08-21
NZ531429A (en) 2005-11-25
WO2003020291A1 (en) 2003-03-13
EP1420802A1 (en) 2004-05-26
CA2458963A1 (en) 2003-03-13
TWI238065B (en) 2005-08-21

Similar Documents

Publication Publication Date Title
NO20041300L (no) Flavanolignanpreparater med okt loselighet
TR200200068T2 (tr) Nematisital triflüorobütenler
DE60010098D1 (de) 28-epirapaloge
CY1110780T1 (el) Τοπικα σκευασματα νεπαφενακης
CY1112560T1 (el) Πνευμονικη μεταφορα των αμινογλυκοσιδων
NO20005839D0 (no) Preparater for behandling av HIV og andre virale infeksjoner
DK1210113T3 (da) Kombinerede vaccinepræparater
CY1110914T1 (el) Δικυκλο-πυραζολες δραστικες ως αναστολεις kinασων, διεργασια για την παρασκευη τους και φαρμακευτικες συνθεσεις που τις περιλαμβανουν
IS6040A (is) Valdekoxib efnablöndur
TR200100805T2 (tr) Tetrahidropiridoeterler
ATE231149T1 (de) (1,8)-naphthyridinderivate derivate mit antiviraler wirkung
NO20015516D0 (no) Preparater og anvendelser av ET743 for behandling av kreft
DK1037650T3 (da) Præparater til behandling af Staphylococcus aureus-infektioner
BR0015490A (pt) Combinações oncolìticas para o tratamento de câncer
PL361134A1 (en) Pharmaceutical solutions of modafinil compounds
EA200300392A1 (ru) Производные пиперазина с мостиковой связью
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
NO20033829L (no) Virusdrepende preparater
ATE316102T1 (de) Peptide mit antiangiogener aktivität
ES2159287T3 (es) Peptidos hemorreguladores.
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
NO20020914D0 (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
DK1131348T3 (da) Regulatoriske/udfoldende peptider af ezrin
DK1173194T3 (da) Rekombinant SP-A til behandlingen eller forebyggelsen af lungeinfektion og -inflammation
IS2797B (is) Bóluefni gegn ISA-veiru

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application